ANAB Stock Summary and Trading Ideas (Anaptysbio | NASDAQ:ANAB)

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Anaptysbio trades on the NASDAQ stock market under the symbol ANAB.

As of August 21, 2026, ANAB stock price climbed to $57.74 with 297,427 million shares trading.

ANAB has a beta of 0.73, meaning it tends to be less sensitive to market movements. ANAB has a correlation of 0.01 to the broad based SPY ETF.

ANAB has a market cap of $1.71 billion. This is considered a Small Cap stock.

Last quarter Anaptysbio reported $26 million in Revenue and -$1.84 earnings per share. This beat revenue expectation by $7 million and missed earnings estimates by -$1.18.

In the last 3 years, ANAB traded as high as $72.36 and as low as $6.11.

The top ETF exchange traded funds that ANAB belongs to (by Net Assets): XBI, VTI, IWM, VXF, IBB.

ANAB has outperformed the market in the last year with a price return of +467.2% while the SPY ETF gained +21.7%. However, in the short term, ANAB had mixed performance relative to the market. It has underperformed in the last 3 months, returning -4.4% vs +3.4% return in SPY. But in the last 2 weeks, ANAB shares have fared better than the market returning +2.0% compared to SPY -1.0%.

ANAB support price is $54.91 and resistance is $58.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANAB shares will trade within this expected range on the day.